It has long been viewed as a potential antifibrotic agent [13], in addition to its modulating effect on insulin resistance through downregulation of TNF, it could be a potential mechanism for improvement in patients with nonalcoholic steatohepatitis (NASH) [12, 14, 15]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.